IFNG and tuberculosis: In vitro TIM3 blockade—in co-culture experiments with MTB-infected macrophages from TB patients with or without HIV co-infection—promotes bacterial killing and enhances IL-1β secretion by infected cells, as well as the IFN-γ release by T cells [12].